Efficacy Testing Market by Service Type, Application and Region - Global Forecast to 2025 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Efficacy Testing Market by Service Type (Antimicrobial/Preservative Efficacy Testing, Disinfectant Efficacy Testing (Surface, Suspension)), Application (Pharmaceutical Manufacturing, Cosmetic & Personal Care Products, Consumer) and Region - Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The global efficacy testing market is projected to reach USD 333 million by 2025 from USD 261 million in 2020, at a CAGR of 5% during the forecast period.

The growth of this market is mainly driven by the increasing use of surface disinfectants and preservatives in pharma, biopharma, and cosmetics industries for contamination control and product stability; growing preference for outsourcing efficacy testing; and the rising adoption of the QbD approach.

By method type, the traditional test method holds the largest share of the antimicrobial/preservative testing market

In the traditional test method, a sample of the pharmaceutical or cosmetic product is inoculated with a microbial suspension of a population of a regulatory recognized key microorganism. This is followed by sampling and the determination of the number of colony-forming units (CFU) and the microbial survival rate with the help of aerobic plate count, surface spread, or membrane filtration techniques after a suitable incubation time. As these test methods are in accordance with the guidelines and standards set by regulatory authorities, they are widely used by service providers.

Asia Pacific: The fastest-growing region in the efficacy testing market

The Asia Pacific market is projected to grow at the highest CAGR during the forecast period, mainly due to the fast-growing pharmaceutical industry in this region, favorable government policies, and the increasing number of pharmaceutical companies establishing manufacturing facilities in APAC countries.

North America: The largest share of the efficacy testing market

North America accounted for the largest share of the efficacy testing market. Factors such as the presence of a well established pharmaceutical industry in the region, the high R&D expenditure, a strong presence of major service providers, and rising outsourcing of analytical testing (including efficacy testing) by pharmaceutical and cosmetic companies in the region are the major factors driving the market growth.

Market Dynamics

Drivers

• Increasing Use of Surface Disinfectants and Preservatives in Pharma, Biopharma, and Cosmetics Industries for Contamination Control and Product Stability
• Rising Focus on Contamination Control
• Increasing Concerns Over Product Stability
• Growing Preference for Outsourcing Efficacy Testing
• Rising Adoption of the Quality by Design Approach

Opportunities

• Emerging Countries in the Asia-Pacific Region

Challenges

• Time-Consuming Process

Companies Mentioned

• 3M Group
• Abbott Analytical
• Accugen Laboratories, Inc.
• Almac Group
• ALS Limited
• Betco
• Bioscience Laboratories, Inc.
• Blutest Laboratories Limited
• Cantel Medical Corporation
• Charles River Laboratories International, Inc.
• Consumer Product Testing Company (CPTC)
• Diversey, Inc.
• Ecolab Inc.
• Eurofins Scientific
• Helvic Laboratories (A Tentamus Company)
• Intertek Group plc
• Lucideon
• Medline Industries, Inc.
• Microchem Laboratory
• MSL Solution Providers
• Nelson Laboratories, LLC (A Sotera Health Company)
• North American Science Associates
• Pacific Biolabs
• Procter & Gamble
• Reckitt Benckiser Group plc
• SGS SA
• Steris plc
• The Clorox Company
• Toxikon
• Wuxi Apptec

For more information about this report visit https://www.researchandmarkets.com/r/7dne74